Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lyell Immunopharma (LYEL) Return on Assets (2021 - 2025)

Historic Return on Assets for Lyell Immunopharma (LYEL) over the last 5 years, with Q3 2025 value amounting to 0.83%.

  • Lyell Immunopharma's Return on Assets fell 5300.0% to 0.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.83%, marking a year-over-year decrease of 5300.0%. This contributed to the annual value of 0.54% for FY2024, which is 2700.0% down from last year.
  • According to the latest figures from Q3 2025, Lyell Immunopharma's Return on Assets is 0.83%, which was down 5300.0% from 0.83% recorded in Q2 2025.
  • In the past 5 years, Lyell Immunopharma's Return on Assets ranged from a high of 0.17% in Q3 2021 and a low of 0.83% during Q2 2025
  • Over the past 5 years, Lyell Immunopharma's median Return on Assets value was 0.23% (recorded in 2023), while the average stood at 0.35%.
  • As far as peak fluctuations go, Lyell Immunopharma's Return on Assets soared by 200bps in 2023, and later plummeted by -5300bps in 2025.
  • Quarter analysis of 5 years shows Lyell Immunopharma's Return on Assets stood at 0.18% in 2021, then fell by -2bps to 0.19% in 2022, then tumbled by -54bps to 0.29% in 2023, then crashed by -108bps to 0.6% in 2024, then tumbled by -37bps to 0.83% in 2025.
  • Its last three reported values are 0.83% in Q3 2025, 0.83% for Q2 2025, and 0.74% during Q1 2025.